Videos

Get to know the different kinds of tumor and blood biomarker tests and the differences between these and genetic tests for an inherited mutation. Find out which tests can be used today for treatment decisions and which are under study or used in clinical trials. Dr. Tripathy explores ways to access these tests, their strengths and limitations, and the hope these tests offer to make personalized medicine a reality. Learn more about our 2024 Conference on Metastatic Breast Cancer.

Hear about drugs that have been approved for metastatic breast cancer over the last 2 years and how they impact each subtype of breast cancer. Learn how these latest approvals compare with previous standard-of-care therapies, what we know, and what we don’t, and hear about the exciting drugs and approaches in the pipeline for the next 3 to 5 years. Learn more about our 2024 Conference on Metastatic Breast Cancer.

Understand how palliative care (supportive oncology) can provide you with the information and tools you need to address impactful side effects of treatment and aid in your overall quality of life. Learn how to access these supportive services no matter where you receive treatment and use it to live well – body, mind, and soul. Learn more about our 2024 Conference on Metastatic Breast Cancer.

Join Stacy Kennedy, MPH, RD, CSO, LDN, CPT, as she provides practical strategies to help you achieve your nutritional goals. Learn how to manage side effects through easy-to-implement eating tips and changes to your diet, better understand your gut health, and find additional resources. Stacy also busts myths and answers participant questions. Learn more about our 2024 Conference on Metastatic Breast Cancer.

Although the psychological impact of this disease is often overlooked in patient care, it is widely documented that addressing these issues and developing coping strategies helps patients navigate the disease process, manage side effects, improve treatment compliance, and help overall psychological function. Patients will learn specific and immediately applicable strategies for coping in the long term with the disease and its psychosocial repercussions. Learn more about our 2024 Conference on Metastatic Breast Cancer.

Living Beyond Breast Cancer, Penn Medicine, and the Basser Center for BRCA held an important webinar on how to assess and understand your breast cancer risk, as well as learn about the risk-reducing surgical options for those who are at high risk for breast cancer or have BRCA1/2 gene mutations. Leading experts from Penn Medicine and the Basser Center for BRCA discussed and provided their insights on the latest in BRCA treatment, breast cancer risk evaluation and genetic counseling, risk-reducing mastectomy options, advancements in breast reconstruction after mastectomy, and post-surgical management and care.

Led by facilitator Ricki Fairley, and featuring two people living with mets, this keynote will discuss the importance of being involved in your own care, ways you can advocate for yourself and your loved ones, the importance of clinical trials and participating in them, and how you can find control in your care when things feel out of control. Learn more about our 2024 Conference on Metastatic Breast Cancer.

If you have been diagnosed with estrogen receptor-positive, HER2-negative metastatic breast cancer you may develop an ESR1 mutation after progression on endocrine therapy. ESR1 mutation testing can help you and your healthcare team make decisions about the most effective treatment options for you. Eleonora Teplinksy, MD explains more about more about this test, who should get tested and when, and how it impacts treatments for metastatic breast cancer.

A diagnosis of estrogen-positive breast cancer at 54 reshaped Monica’s perspective, making exercise about movement and regaining control of her life. Recently, she’s been trying something new that fosters a shared experience with others who have been impacted by breast cancer. Meet all of the women in our BeACTive series.

Megan R, a marathon runner, is redefining her fitness expectations and finding a new joy in exercise during treatment for an early-stage breast cancer recurrence at 46. Meet all of the women in our BeACTive series.

Amanda, a working mom, recognizes the power of exercise in relieving stress and anxiety as well as breast cancer treatment side effects. A diagnosis of early-stage breast cancer at 40 prompted Amanda to prioritize her health and find ways to cope with the effects of anti-estrogen therapies to prevent recurrence. Meet all of the women in our BeACTive series.

Nancy, a dance and movement psychotherapist, thrives through movement, navigating difficult emotions in the face of a metastatic breast cancer diagnosis. Though breast cancer impacts her endurance and stamina, especially after developing lymphedema, Nancy remains committed to moving her body for expression and fitness. Meet all of the women in our BeACTive series.